Table 3.
Characteristics between survival and death subgroups in the liver failure group
| Characteristics | Survival subgroup (n = 12) | Death subgroup (n = 10) | P |
|---|---|---|---|
| Gender, n (%) | |||
| Male | 9 (75.0) | 3 (3.0) | 0.03* |
| Female | 3 (25.0) | 7 (7.0) | |
| PSS, median (range) | 1.00 (6.00–12.00) | 12.00 (7.00–17.00) | 0.05* |
| Age (years), median (range) | 47.50 (36.00–6.00) | 57.50 (42.00–72.00) | 0.04* |
| Days since onset (days), median (range) | 2.00 (2.00–8.00) | 3.00 (2.00–4.00) | 0.96 |
| Length of in-hospital stay (days), median (range) | 9.00 (6.00–17.00) | 3.00 (2.00–5.00) | <0.01** |
| AST (U/L), median (range) | 5365.50 (97.00–8268.00) | 402.50 (716.00–8369.00) | 0.49 |
| ALT (U/L), median (range) | 5213.00 (1005.00–7049.00) | 503.50 (508.00–10388.00) | 0.87 |
| TBIL (μmol/L), median (range) | 59.30 (44.30–214.90) | 87.35 (16.80–155.70) | 0.59 |
| PT (s), median (range) | 2.45 (11.40–32.90) | 33.25 (16.30–81.50) | 0.01** |
| INR, median (range) | 2.14 (1.13–2.90) | 2.90 (1.48–6.84) | <0.01** |
| Lac (mmol/L), median (range) | 2.25 (.80–3.50) | 7.55 (2.08–15.00) | <0.01** |
| ALB (g/L), median (range) | 40.30 (34.30–56.00) | 34.10 (31.00–36.10) | <0.01** |
| TP (g/L), median (range) | 64.65 (49.70–75.80) | 53.05 (48.20–65.40) | 0.02** |
| NH3 (μmol/L), median (range) | 50.50 (16.00–121.00) | 94.00 (28.00–235.00) | 0.02** |
| Hb (g/L), median (range) | 159.00 (12.00–2.00) | 139.50 (11.00–168.00) | 0.06 |
| PLT (109/L), median (range) | 150.50 (65.00–213.00) | 73.50 (22.40–352.00) | 0.74 |
| Amy (U/L), median (range) | 107.00 (42.00–158.00) | 116.00 (9.00–284.00) | 0.15 |
| Lipase (U/L), median (range) | 233.50 (122.00–984.00) | 557.00 (261.00–1713.00) | 0.02 |
| Cre (μmol/L), median (range) | 64.00 (39.00–88.00) | 57.00 (38.75–281.00) | 0.41 |
*P < 0.05.
**P < 0.01.